§ BIOTECHNOLOGY
USD · Biotechnology

NTLA

INTELLIA THERAPEUTICS INC
USDSector · BiotechnologyBeta · 2.00
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
198 increased/new, 88 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B1.55EPS (TTM)-3.83
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
ARK Investment Management LLC14.5M1.4%+2%
BlackRock, Inc.12.2M0.0%+18%
State Street6.9M0.0%+8%
VANGUARD PORTFOLIO MANAGEMENT LLC6.2Mn/an/a
DE Shaw5.7M0.0%+7%
VANGUARD CAPITAL MANAGEMENT LLC5.1Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for NTLA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER92.3% · 0 holders
OTHER4.1% · 216 holders
DEALER / BANK1.2% · 32 holders
PASSIVE / INDEX1.1% · 10 holders
QUALITY / COMPOUNDER0.5% · 20 holders
ACTIVIST0.4% · 1 holder
SYSTEMATIC / QUANT0.3% · 8 holders
TACTICAL / MACRO0.1% · 5 holders
INCOME / DEFENSIVE0.0% · 15 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for NTLA in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention NTLA yet.